MARKET

DRRX

DRRX

DURECT
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.330
-0.100
-6.99%
After Hours: 1.350 +0.02 +1.50% 19:42 04/03 EDT
OPEN
1.450
PREV CLOSE
1.430
HIGH
1.460
LOW
1.250
VOLUME
661.43K
TURNOVER
--
52 WEEK HIGH
3.949
52 WEEK LOW
0.5000
MARKET CAP
260.44M
P/E (TTM)
-11.0649
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DRRX stock price target is 4.720 with a high estimate of 6.00 and a low estimate of 2.100.

EPS

DRRX News

More
  • FDA accepts Innocoll application for post-surgical pain implant
  • Seeking Alpha - Article · 03/26 17:10
  • Edited Transcript of DRRX earnings conference call or presentation 3-Mar-20 9:30pm GMT
  • Thomson Reuters StreetEvents · 03/23 19:30
  • Novartis Price Fixing, And Other News: The Good, Bad And Ugly Of Biopharma
  • Seeking Alpha - Article · 03/05 20:47
  • The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies
  • Benzinga · 03/04 12:37

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About DRRX

Durect Corporation is a biopharmaceutical company with research and development programs. The Company's products candidates include DUR-928, oral for metabolic/lipid disorders, and DUR-928, injectable for acute organ injuries. Its other product candidates include POSIMIR (controlled release injection of bupivacaine), REMOXY (oral controlled release oxycodone), ORADUR-ADHD, ELADUR (controlled release injection of bupivicane), Relday (risperidone), ORADUR-based opioid (hydromorphone) and SABER-based ophthalmic. The Company's ALZET product line consists of miniature, implantable osmotic pumps and accessories used for experimental research in mice, rats and other laboratory animals. The Company also manufactures and sells osmotic pumps used in laboratory research and design; and develops and manufactures a range of standard and custom biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products.
More

Webull offers kinds of DURECT Corporation stock information, including NASDAQ:DRRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRRX stock news, and many more online research tools to help you make informed decisions.